Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells
Pei‐Ming Yang, Li-Shan Lin, Tsang-Pai Liu
Biomolecules (2020) Vol. 10, Iss. 1, pp. 117-117
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

RRM2 Regulates Sensitivity to Sunitinib and PD‐1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway
Wei Xiong, Bin Zhang, Haixin Yu, et al.
Advanced Science (2021) Vol. 8, Iss. 18
Open Access | Times Cited: 108
RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer
Yueyue Yang, Jiafei Lin, Susu Guo, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 130
Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer
Tzu‐Jen Kao, Chung-Che Wu, Nam Nhut Phan, et al.
Aging (2021) Vol. 13, Iss. 14, pp. 17970-17970
Open Access | Times Cited: 90
Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer
Gangga Anuraga, Wei‐Jan Wang, Nam Nhut Phan, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 11, pp. 1089-1089
Open Access | Times Cited: 60
Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer
Zanwen Zuo, Zerong Zhou, Yuzhou Chang, et al.
Genes & Diseases (2022) Vol. 11, Iss. 1, pp. 218-233
Open Access | Times Cited: 50
Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression
Xiangpeng Tan, Yan He, Jing Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 31
PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer?
Milad Ashrafizadeh, Ali Zarrabi, Saeed Samarghandian, et al.
European Journal of Pharmacology (2020) Vol. 881, pp. 173226-173226
Closed Access | Times Cited: 62
Autophagy, an accomplice or antagonist of drug resistance in HCC?
Yafei Wu, Jigang Zhang, Qin Li
Cell Death and Disease (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 50
Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents
Pratibha Pandey, Deena Elsori, Rahul Kumar, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Potential Therapeutic and Prognostic Values of LSM Family Genes in Breast Cancer
Hoang Dang Khoa Ta, Wei‐Jan Wang, Nam Nhut Phan, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4902-4902
Open Access | Times Cited: 37
The mechanisms and therapeutic targets of ferroptosis in cancer
Long Ye, Fengyan Jin, Shaji Kumar, et al.
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 11, pp. 965-986
Closed Access | Times Cited: 37
Prognostic and Genomic Analysis of Proteasome 20S Subunit Alpha (PSMA) Family Members in Breast Cancer
Chung-Chieh Chiao, Yen-Hsi Liu, Nam Nhut Phan, et al.
Diagnostics (2021) Vol. 11, Iss. 12, pp. 2220-2220
Open Access | Times Cited: 36
Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis
Ata Moghimi, Nasrin Bani Hosseinian, Mahdi Mahdipour, et al.
Cancer Reports (2024) Vol. 7, Iss. 8
Open Access | Times Cited: 5
Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients
Do Thi Minh Xuan, Chung-Che Wu, Tzu‐Jen Kao, et al.
Aging (2021) Vol. 13, Iss. 22, pp. 24882-24913
Open Access | Times Cited: 29
Chlorogenic acid inhibits proliferation in human hepatoma cells by suppressing noncanonical NF-κB signaling pathway and triggering mitochondrial apoptosis
Yanfei Jiang, Hao Nan, Na Shi, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 3, pp. 2351-2364
Open Access | Times Cited: 28
Comprehensive Analysis of Prognostic and Genetic Signatures for General Transcription Factor III (GTF3) in Clinical Colorectal Cancer Patients Using Bioinformatics Approaches
Gangga Anuraga, Wanchun Tang, Nam Nhut Phan, et al.
Current Issues in Molecular Biology (2021) Vol. 43, Iss. 1, pp. 2-20
Open Access | Times Cited: 27
A novel four-gene of iron metabolism-related and methylated for prognosis prediction of hepatocellular carcinoma
Huimin Shen, Hao Wu, Fengkai Sun, et al.
Bioengineered (2020) Vol. 12, Iss. 1, pp. 240-251
Open Access | Times Cited: 21
Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
Wenjing Su, Peizhi Lu, Yong Wu, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 20
Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis
Wei Wang, Fan Pan, Xinrong Lin, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway
Hui Xu, Bin Li
Bioengineered (2022) Vol. 13, Iss. 5, pp. 12876-12887
Open Access | Times Cited: 13
Circadian rhythm-related factors of PER and CRY family genes function as novel therapeutic targets and prognostic biomarkers in lung adenocarcinoma
Chin‐Chou Wang, Wei-Hsun Lin, Su‐Chi Ku, et al.
Aging (2022) Vol. 14, Iss. 22, pp. 9056-9089
Open Access | Times Cited: 13
Analysis of LAGEs Family Gene Signature and Prognostic Relevance in Breast Cancer
Hoang Dang Khoa Ta, Wanchun Tang, Nam Nhut Phan, et al.
Diagnostics (2021) Vol. 11, Iss. 4, pp. 726-726
Open Access | Times Cited: 17
A Five-Gene-Based Prognostic Signature for Hepatocellular Carcinoma
Dazhi Tian, Yang Yu, Li Zhang, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 17
Gut microbiome dysbiosis in patients with hepatitis B virus-related hepatocellular carcinoma after extended hepatectomy liver failure
Yuchong Peng, Jing‐Xuan Xu, Chuan-Fa Zeng, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 10, pp. 549-549
Open Access | Times Cited: 12
FOXM1-activated IGF2BP3 promotes cell malignant phenotypes and M2 macrophage polarization in hepatocellular carcinoma by inhibiting ferroptosis via stabilizing RRM2 mRNA in an m6A-dependent manner
Heng Gao, Lei Shi, Jinfeng Liu, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top